FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel derivatives of sulfonamide of the general formula (I): wherein A means a substitute chosen from 5- or 6-membered heteroaromatic ring comprising 1 or 2 heteroatoms chosen from oxygen (O), nitrogen (N) or sulfur (S) optionally substituted with 1 or 2 halogen atoms, (C1-C4)-alkyl or phenyl radical, or 5- or 6-membered heteroaryl radical comprising 1 or 2 atoms of O, N or S; bicyclic heteroaromatic ring comprising from 1 to 3 heteroatoms chosen from O, N or S and optionally substituted with 1 or 2 halogen atoms or (C1-C4)-alkyl; R1 means hydrogen atom (H), (C1-C4)-alkyl, benzyl; n means 0, 1, 2, 3 or 4; R2 means -NRR5 or the group of the formula: wherein a dotted line means optional chemical bond; R, R4 and R5 mean independently H or (C1-C4)-alkyl; or one of its physiologically acceptable salts. Compounds of the formula (1) possess antagonistic activity with respect to serotonin HT6-receptors that allows their using in pharmaceutical composition and for preparing a medicament.
EFFECT: valuable medicinal properties of derivatives and pharmaceutical composition.
10 cl, 2 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 1-SULPHONYL-4-AMINOALCOXYINDOLE AND PHARMACEUTICAL COMPOSITION WITH 5-=T6 RECEPTOR MODULATOR ACTIVITY | 2003 |
|
RU2323927C2 |
NOVEL ARYLALKYLINDOLES SHOWING AFFINITY TO SEROTONIN RECEPTOR AND USEFUL AS DRUGS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | 2003 |
|
RU2320663C2 |
NOVEL TETRACYCLIC ARYLSULFONYL-INDOLES WITH AFFINITY FOR SEROTONIN RECEPTORS, ACCETABLE AS MEDICATIONS, METHOD OF THEIR OBTAINING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2003 |
|
RU2340619C2 |
COMPOSITIONS AND METHODS FOR TREATING COGNITIVE DISORDERS | 2005 |
|
RU2420318C2 |
INDOLYLALKYLAMINE DERIVATIVES AS 5-HYDROHYTRIPTAMINE-6 LIGANDS | 2002 |
|
RU2309157C2 |
COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS | 2005 |
|
RU2406725C2 |
ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROISOQUINOLINES AND USE THEREOF FOR INHIBITING NOREPINEPHRINE, DOPAMINE AND SEROTONIN REUPTAKE | 2005 |
|
RU2388751C2 |
HETEROCYCLIC ARYL SULPHONES, SUITABLE FOR TREATING DISORDERS RESPONSIVE TO 5HT RECEPTOR MODULATION | 2007 |
|
RU2451012C2 |
LIGANDS OF 5-HT RECEPTORS, PHARMACEUTICAL FORMULATION, PRODUCTION METHOD AND MEDICAL PRODUCT | 2006 |
|
RU2329044C1 |
MUSCARINIC AGONISTS | 2001 |
|
RU2269523C2 |
Authors
Dates
2007-02-10—Published
2002-11-08—Filed